Dupilumab efficacy in patients with COPD and type 2 inflammation irrespective of mortality risk score

被引：0
|
作者：
Vogelmeier, Claus [1 ]
Rabe, Klaus F. [2 ]
Bhatt, Surya P. [3 ]
Hanania, Nicola A. [4 ]
Bafadhel, Mona [5 ]
Christenson, Stephanie A. [6 ]
Papi, Alberto [7 ]
Singh, Dave [8 ]
Laws, Elizabeth [9 ]
Maloney, Jennifer [9 ,10 ]
Lu, Xin [9 ]
Bauer, Deborah [9 ]
Bansal, Ashish [10 ]
Robinson, Lacey B. [11 ]
Abdulai, Raolat M. [11 ]
机构：
[1] Univ Marburg, German Ctr Lung Res DZL, Dept Med, Marburg, Germany
[2] German Ctr Lung Res, LungenClin Grosshansdorf & Christian Albrechts Uni, Airway Res Ctr North, Grosshansdorf, Germany
[3] Univ Alabama Birmingham, Div Pulm, Birmingham, AL USA
[4] Baylor Coll Med, Dept Med, Sect Pulm & Crit Care Med, Houston, TX USA
[5] Kings Coll London, Fac Life Sci & Med, Kings Ctr Lung Hlth, Sch Immunol & Microbial Sci, London, England
[6] Univ Calif San Francisco, Div Pulm, San Francisco, CA USA
[7] Univ Ferrara, Ferrara, Italy
[8] Univ Manchester, Manchester Univ NHS Fdn Trust, Manchester, England
[9] Sanofi, Bridgewater, NJ USA
[10] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[11] Sanofi, Cambridge, MA USA
来源：
EUROPEAN RESPIRATORY JOURNAL | 2024年 / 64卷
关键词：
D O I：
10.1183/13993003.congress-2024.PA4782
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] EFFICACY AND SAFETY OF DUPILUMAB FOR COPD WITH TYPE 2 INFLAMMATION
    Bhatt, Surya P.
    Rabe, Klaus F.
    Hanania, Nicola A.
    Vogelmeier, Claus F.
    Cole, Jeremy
    Bafadhel, Mona
    Christenson, Stephanie
    Papi, Alberto
    Singh, Dave
    Laws, Elizabeth
    Mannent, Leda L. M.
    Mortensen, Eric R.
    Maloney, Jennifer
    Lu, Xin
    Bauer, Deborah J.
    Bansal, Ashish
    Robinson, Lacey
    Abdulai, Raolat
    CHEST, 2023, 164 (04) : 6531A - 6534A
  • [2] Dupilumab helps with COPD with type 2 inflammation
    Krome, Susanne
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2024, 149 (1-2) : 10 - 11
  • [3] Dupilumab helps with COPD with type 2 inflammation
    Krome, Susanne
    PNEUMOLOGIE, 2024, 78 (05): : 290 - 290
  • [4] Efficacy and Safety of Dupilumab for COPD with Type 2 Inflammation Indicated by Elevated Eosinophils
    Bhatt, S.
    Watz, H.
    Rabe, K.
    Hanania, N.
    Vogelmeier, C.
    Cole, J.
    Bafadhel, M.
    Christenson, S.
    Papi, A.
    Singh, D.
    Laws, E.
    Lu, X.
    Bauer, D.
    Mortensen, E.
    Maloney, J.
    Bansal, A.
    Robinson, L.
    Abdulai, R.
    PNEUMOLOGIE, 2024, 78 : S64 - S64
  • [5] Dupilumab for COPD with Type 2 Inflammation (Elevated Eosinophils)
    Moody, J.
    Bardin, P.
    Bhatt, S.
    Rabe, K.
    Hanania, N.
    Vogelmeier, C.
    Cole, J.
    Bafadhel, M.
    Christenson, S.
    Papi, A.
    Singh, D.
    Laws, E.
    Lu, X.
    Bauer, D.
    Mortensen, E.
    Maloney, J.
    Bansal, A.
    Robinson, L.
    Abdulai, R.
    RESPIROLOGY, 2024, 29 : 47 - 48
  • [6] Dupilumab efficacy and safety in patients with moderate-to-severe COPD with type 2 inflammation: pooled analysis of BOREAS and NOTUS
    Bhatt, Surya
    Rabe, Klaus F.
    Hanania, Nicola
    Vogelmeier, Claus F.
    Bafadhel, Mona
    Christenson, Stephanie
    Papi, Alberto
    Singh, Dave
    Laws, Elizabeth
    Akinlade, Bolanle
    Maloney, Jennifer
    Lu, Xin
    Bauer, Deborah
    Bansal, Ashish
    Abdulai, Raolat M.
    Robinson, Lacey B.
    Bhatt, Surya
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [7] Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
    Bhatt, Surya P.
    Rabe, Klaus F.
    Hanania, Nicola A.
    Vogelmeier, Claus F.
    Bafadhel, Mona
    Christenson, Stephanie A.
    Papi, Alberto
    Singh, Dave
    Laws, Elizabeth
    Patel, Naimish
    Yancopoulos, George D.
    Akinlade, Bolanle
    Maloney, Jennifer
    Lu, Xin
    Bauer, Deborah
    Bansal, Ashish
    Abdulai, Raolat M.
    Robinson, Lacey B.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (24): : 2274 - 2283
  • [8] Efficacy and Safety of Dupilumab in Patients With Moderate-to-Severe COPD and Type 2 Inflammation: Phase 3 NOTUS Trial
    Bhatt, S. P.
    Rabe, K. F.
    Hanania, N. A.
    Vogelmeier, C. F.
    Bafadhel, M.
    Christenson, S. A.
    Papi, A.
    Singh, D.
    Laws, E.
    Akinlade, B.
    Maloney, J.
    Lu, X.
    Bauer, D.
    Bansal, A.
    Abdulai, R. M.
    Robinson, L. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [9] Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts
    Bhatt, S. P.
    Rabe, K. F.
    Hanania, N. A.
    Vogelmeier, C. F.
    Cole, J.
    Bafadhel, M.
    Christenson, S. A.
    Papi, A.
    Singh, D.
    Laws, E.
    Mannent, L. P.
    Patel, N.
    Staudinger, H. W.
    Yancopoulos, G. D.
    Mortensen, E. R.
    Akinlade, B.
    Maloney, J.
    Lu, X.
    Bauer, D.
    Bansal, A.
    Robinson, L. B.
    Abdulai, R. M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (03): : 205 - 214
  • [10] Late Breaking Abstract - Efficacy and Safety of Dupilumab for COPD with Type 2 Inflammation Indicated by Elevated Eosinophils
    Bhatt, Surya
    Rabe, Klaus F.
    Hanania, Nicola A.
    Vogelmeier, Claus
    Cole, Jeremy
    Bafadhel, Mona
    Christenson, Stephanie A.
    Papi, Alberto
    Singh, Dave
    Laws, Elizabeth
    Mannent, Leda
    Mortensen, Eric
    Maloney, Jennifer
    Lu, Xin
    Bauer, Deborah
    Bansal, Ashish
    Robinson, Lacey B.
    Abdulai, Raolat M.
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
12345